154 related articles for article (PubMed ID: 38041175)
21. The value on SUV-derived parameters assessed on
Liao X; Liu M; Li S; Huang W; Guo C; Liu J; Xiong Y; Zhang J; Fan Y; Wang R
BMC Med Imaging; 2023 Apr; 23(1):49. PubMed ID: 37020286
[TBL] [Abstract][Full Text] [Related]
22. Predictive risk factors for mediastinal lymph node metastasis in clinical stage IA non-small-cell lung cancer patients.
Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
J Thorac Oncol; 2012 Aug; 7(8):1246-51. PubMed ID: 22659962
[TBL] [Abstract][Full Text] [Related]
23. Predicting pathological lymph node status in clinical stage IA peripheral lung adenocarcinoma.
Aokage K; Suzuki K; Wakabayashi M; Mizutani T; Hattori A; Fukuda H; Watanabe SI
Eur J Cardiothorac Surg; 2021 Jul; 60(1):64-71. PubMed ID: 33514999
[TBL] [Abstract][Full Text] [Related]
24. Radiologic Predictors for Clinical Stage IA Lung Adenocarcinoma with Ground Glass Components: A Multi-Center Study of Long-Term Outcomes.
Li Z; Ye B; Bao M; Xu B; Chen Q; Liu S; Han Y; Peng M; Lin Z; Li J; Zhu W; Lin Q; Xiong L
PLoS One; 2015; 10(9):e0136616. PubMed ID: 26339917
[TBL] [Abstract][Full Text] [Related]
25. New perspective to evaluate N1 staging: The peripheral lymph node metastasis status of non-small cell lung cancer.
Zhang J; Liu L; Wang G; Huang C; Chen Y; Zhang Y; Guo C; Li S
Thorac Cancer; 2019 Dec; 10(12):2253-2258. PubMed ID: 31617316
[TBL] [Abstract][Full Text] [Related]
26. Pre-surgical assessment of mediastinal lymph node metastases in Stage IA non-small-cell lung cancers.
Wang Y; Zhu Y; Yip R; Lee DS; Flores RM; Kaufman A; Henschke CI; Yankelevitz DF;
Clin Imaging; 2020 Dec; 68():61-67. PubMed ID: 32570011
[TBL] [Abstract][Full Text] [Related]
27. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
Li X; Zhang H; Xing L; Xu X; Xie P; Ma H; Zhang L; Chen M; Sun X; Xu W; Chen L; Yu J
Clin Lung Cancer; 2013 Sep; 14(5):568-73. PubMed ID: 23835164
[TBL] [Abstract][Full Text] [Related]
28. Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT.
Park HK; Jeon K; Koh WJ; Suh GY; Kim H; Kwon OJ; Chung MP; Lee KS; Shim YM; Han J; Um SW
Respirology; 2010 Nov; 15(8):1179-84. PubMed ID: 20573058
[TBL] [Abstract][Full Text] [Related]
29. Importance of Lymph Node Evaluation in ≤2-cm Pure-Solid Non-Small Cell Lung Cancer.
Choi S; Yoon DW; Shin S; Kim HK; Choi YS; Kim J; Shim YM; Cho JH
Ann Thorac Surg; 2024 Mar; 117(3):586-593. PubMed ID: 36608755
[TBL] [Abstract][Full Text] [Related]
30. Predictive Factors for Lymph Node Metastasis in Clinical Stage I Part-Solid Lung Adenocarcinoma.
Lee SY; Jeon JH; Jung W; Chae M; Hwang WJ; Hwang Y; Cho S; Chung JH; Kim K; Jheon S
Ann Thorac Surg; 2021 Feb; 111(2):456-462. PubMed ID: 32652067
[TBL] [Abstract][Full Text] [Related]
31. Comparison between solid component size on thin-section CT and pathologic lymph node metastasis and local invasion in T1 lung adenocarcinoma.
Hayashi H; Ashizawa K; Ogihara Y; Nishida A; Matsumoto K; Yamasaki N; Nagayasu T; Fukuda M; Honda S; Uetani M
Jpn J Radiol; 2017 Mar; 35(3):109-115. PubMed ID: 28110435
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for lymph node metastasis and surgical methods in patients with early-stage peripheral lung adenocarcinoma presenting as ground glass opacity.
Wang Y; Jing L; Wang G
J Cardiothorac Surg; 2020 Aug; 15(1):121. PubMed ID: 32782020
[TBL] [Abstract][Full Text] [Related]
33. Lobe-Specific Lymph Node Dissection May be Feasible for Clinical N0 Solid-Predominant Part-Solid Lung Adenocarcinoma With Solid Component Diameter ≤ 2 cm.
Wo Y; Li H; Chen Z; Peng Y; Zhang Y; Ye T; Jiang W; Sun Y
Clin Lung Cancer; 2023 Jul; 24(5):437-444. PubMed ID: 37029008
[TBL] [Abstract][Full Text] [Related]
34. Lymph node metastasis in clinical stage IA peripheral lung cancer.
Wang L; Jiang W; Zhan C; Shi Y; Zhang Y; Lin Z; Yuan Y; Wang Q
Lung Cancer; 2015 Oct; 90(1):41-6. PubMed ID: 26212683
[TBL] [Abstract][Full Text] [Related]
35. Intrapulmonary lymph node metastasis is common in clinically staged IA adenocarcinoma of the lung.
Zhang D; Chen X; Zhu D; Qin C; Dong J; Qiu X; Fan M; Zhuo Q; Tang X
Thorac Cancer; 2019 Feb; 10(2):123-127. PubMed ID: 30468025
[TBL] [Abstract][Full Text] [Related]
36. Correlation study between flash dual source CT perfusion imaging and regional lymph node metastasis of non-small cell lung cancer.
Huang T; Sun H; Luo X; Zhang X; Jin K; Wang F; Sun L; Cheng N; Wu S; Lou Q; Li B
BMC Cancer; 2020 Jun; 20(1):547. PubMed ID: 32532248
[TBL] [Abstract][Full Text] [Related]
37. Tumour standardized uptake value on positron emission tomography is a novel predictor of adenocarcinoma in situ for c-Stage IA lung cancer patients with a part-solid nodule on thin-section computed tomography scan.
Hattori A; Suzuki K; Matsunaga T; Fukui M; Tsushima Y; Takamochi K; Oh S
Interact Cardiovasc Thorac Surg; 2014 Mar; 18(3):329-34. PubMed ID: 24351509
[TBL] [Abstract][Full Text] [Related]
38. Preoperative risk factors of lymph node metastasis in clinical N0 lung adenocarcinoma of 3 cm or less in diameter.
Fang C; Xiang Y; Han W
BMC Surg; 2022 Apr; 22(1):153. PubMed ID: 35488235
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of integrated positron emission tomography and computed tomography accuracy in detecting lymph node metastasis in patients with adenocarcinoma vs squamous cell carcinoma.
Billè A; Okiror L; Skanjeti A; Errico L; Arena V; Penna D; Ardissone F; Pelosi E
Eur J Cardiothorac Surg; 2013 Mar; 43(3):574-9. PubMed ID: 22689182
[TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up of persistent pulmonary pure ground-glass nodules with deep learning-assisted nodule segmentation.
Qi LL; Wu BT; Tang W; Zhou LN; Huang Y; Zhao SJ; Liu L; Li M; Zhang L; Feng SC; Hou DH; Zhou Z; Li XL; Wang YZ; Wu N; Wang JW
Eur Radiol; 2020 Feb; 30(2):744-755. PubMed ID: 31485837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
